Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 0 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 1 |
Share price forecast in CNY
The 4 analysts offering 12 month price targets for Alphamab Oncology have a median target of 5.24, with a high estimate of 7.46 and a low estimate of 2.51. The median estimate represents a 96.94% increase from the last price of 2.66.
High | 180.3% | 7.46 |
Med | 96.9% | 5.24 |
Low | -5.5% | 2.51 |
Earnings history & estimates in CNY
Average growth rate | +33.07% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +22.69% |
More ▼